Regulatory data is notoriously scattered across silos, but a new tool from KeyPedia aims to change that by plugging global enforcement records directly into the AI assistants life science professionals already use. The company has released a free Model Context Protocol (MCP) connector that brings its AI-native regulatory records into popular tools like Claude and ChatGPT, effectively giving teams a conversational window into FDA databases and beyond.
Based in Brooklyn, NY, KeyPedia announced the launch on October 29, 2026. The service lets life science teams query citable global regulatory records using natural language, eliminating the need for traditional API calls or manual document retrieval. Where developers previously had to interact with openFDA through code, KeyPedia MCP now allows supported AI assistants to access datasets alongside AI-ready records such as premarket filings, guidances, recall data, FDA Form 483 observations, warning letters, and inspection histories — all consolidated into a single interface.
The connector works by linking AI assistants to KeyPedia’s data layer, which aggregates and structures records from the FDA, MHRA, ANVISA, the EAEU, and other global regulators. This structure helps teams move fluidly from a question to relevant evidence and then into a research, quality, or supplier-review workflow.
Also worth a look: Bigly Sales gives websites a voice with Talk Kit, an AI agent that talks back and Synergy Logistics rebrands after 50 years, unveils hybrid WMS for offline resilience.
“The purpose of our MCP service is to offer industry a data layer that supports the kind of AI workflows the FDA is building with tools like Elsa,” said George Kwiecinski, co-founder and CEO of KeyPedia.
KeyPedia’s strategy explicitly mirrors the FDA’s own internal AI ambitions. In its May 2026 Elsa and HALO announcement, the agency described consolidating more than 40 application and submission data sources, systems, and portals into HALO, and beginning to integrate it with Elsa. The goal was to let staff query data and build workflows without manually uploading documents into each conversation.
KeyPedia’s “Elsa for industry” approach applies that same principle to public regulatory evidence: organize the data, connect it to an AI assistant, and make it usable in day-to-day work. The company emphasizes that it is an independent service built on public sources and its own processing, and is separate from the FDA’s internal Elsa system and nonpublic data.
Recognizing that organizations are at different stages of AI adoption, KeyPedia has built the MCP service in tiers. “We understand that everyone is at a different point in their AI journey. We launched this product to give industry a phased approach to adoption,” Kwiecinski said.
The free version gives any registered user access to openFDA datasets and KeyPedia’s AI-ready FDA records immediately upon connection. Enterprise accounts and KeyPedia subscribers receive additional proprietary data and methods, including KRA Scores. These scores summarize risk within a defined search or group of records, supporting prioritization and professional review — though comparisons should account for the scope and context of the facilities, products, or records being assessed.
Getting started is straightforward. The KeyPedia Connector guide includes setup instructions and workflow examples. Users can add KeyPedia from the connector directory of a supported AI assistant such as Claude or ChatGPT. Once connected, they can begin with a question about a manufacturer, inspection, or warning letter and build from the results.
KeyPedia describes itself as the intelligence layer for global regulatory data. It tracks and decodes FDA and global enforcement data to help professionals understand post-market quality and compliance risk, detect emerging issues, and make informed decisions about products, facilities, and suppliers.
Why it matters: For life science professionals drowning in fragmented regulatory documents, this connector offers a practical on-ramp to AI-assisted research without requiring technical expertise. By mirroring the FDA’s own internal AI strategy, KeyPedia is betting that the same conversational data-access model that works for regulators will also transform how industry teams vet suppliers, track recalls, and manage compliance risk.
Zephaniah Odidika
KeyPedia
+1 (347) 882-1377
